Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Riboflavin/Ultraviolet A Cross-linked Human Donor Corneas as Carriers for the Boston Keratoprosthesis

NCT01582880 is registered in ClinicalTrials.gov with Joseph B. Ciolino, MD as lead sponsor.

NCT NCT01582880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01582880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Riboflavin/Ultraviolet A Cross-linked Human Donor Corneas as Carriers for the Boston Keratoprosthesis
Lead sponsor
Joseph B. Ciolino, MD
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2012
Completion date
March 31, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, chemical injuries, lupus erythematosus, systemic, ocular cicatricial pemphigoid, other autoimmune diseases, rheumatoid arthritis, stevens johnson syndrome, unspecified complication of corneal transplant